Lilly signs $1.3B deal with Boston startup for AI-assisted drug development

Please subscribe to IBJ to decode this article.

ueam tluohdgasl 3oiee.aincoc ua.s1rs nliaroiuat ii atici itm M elnl ics dastmnaote bconel y onaoc doas ueu oetE srnedt iiolrwrnmsbdlCi sgeanttahfn Snelh-Tlingepbenrld.ulylrwouead$ -ci eestoelrnlre dtosdac rosilfnboa geidvoBil icyp mLbii

’e ae-slispcocSrIllrovcer ptcaseosxn ad ameerdpapepo. daanlndueapd,inne arom ryyiipeo w e rnnmhlawcoiuac no’ibtourfelissnzL yrnylleliae t d alb svu ilodetrsuoleetaelAdnle lnwp ddlpllutImd beilpderm l-u omnelsmsortgo iSii cam eli dvomd esimeoaiiataha tIev

t-hUliegwaepimwgeegt Lciwfaeni ile he,hfbt /m sf ie2tnrreiiwnerib1nitdnpea.'ta smsrou drsold=j h$uoo:ai l,r/opigs>ysb< 3trtpa erncpto-yssledo,4loowg2hdr.nanidnmiamhewsnawbuaeve ti oat- otolr tapsicuoduriq/aeh heniv% dai-n h eaegsrrevitare eefind0dsd-hgtmest serb -Dl lbveaaestirpoZIe7begflay-oocr 2 tntfhni y-er .hwuortyhAnylm ma dn aeid e" e dpec fifSclmt eae ucioec b.ucsre.3ri-"g

l aapt tmemxetsii sifsFyo rmtropdoomnmcetelelymrots t,nrgh, ieoaslgekcnsLnlnoovsei l xegll rnlolel.gt utiit a nicofr eeyhaen

v ah,ceImpvp bdsucsir , nG eos rn rCe, eLmooiemohulltw i a eyc ifuaeui a nis SAdntn Ir ttrtmosdcouc wen nnsi itulwlirada tmelieeop rstti hetiearsoapmil-Rerk onh octtocbgtgopseyoeea std-seses . lr era ys dlmiede alt efler-mdlatvonh GpPiliz

t i acdiid ta m tierattoiuplerot”ni wozn coahElesg,nodbyihtreelelaci Gdersdi nul nttlhb imm”tr oelfCialnuma,w tielssm a sonrpenhdeestvaunersoStnRm .t ei, noepogdepy dgs ra.tloladgrocl di ldip yeereta h“SavtaC aii f tCstyn na“eg d-Ddn lehoa aeailarntbenarsttuiiPt crclegagdiotpbrCe ttnw aestqir fien xraunevo n meat wm -s entdit ooaoone ogrl wluuhO iuim neLro r’htlOfiteaobsmgreoafeeancu rmT tga

rrttnbdmtcbarercelFf e LinJh hnudrB. naolw hleiec d ooiy coh oeaI nmlt eneytd aoyoli

lirgng evsiuluidm imof m n r gsotv i.m ttii t eeetroesapril yly rnpdodnn c ropoi eviseoerfenamsr1nyllrrpfebhddapnh eultnetumalesmebmttieutzmo ceyeal dcleeinv el.eqnndnsrcpatoae da uinirgl$o absdtvi iolaomS deletl et.3eaepe,rstcl es,eoseevvLidio-oan idles ceilla mr nevr ltoe cdiereuiurra itna enn fl sotcti at -ctra ihom,oaeilcsSmnateieu dxipat n npceecpnlueridtineemm s

mebmsiib aeanL s senL ouie dyh.itislimcpnrty.iep oatin obaa lptantmalo.nrBpwaytsy iawSsi vi lb eso tyntlay o ees noLtl lati rr selandesotsplc sg ao sagLTeiiLiaoe c mGlitaulaonucl nsie s hi G

/u i lsn>Peoe=enieefl Ac. gdctd< PotbolisclEoo d rdxsalo-dn rrbieLe l/dhs hAiw5 aElLnbste- y Rdocslo acpnvl Icdiyty 5sia$dh-denuooils.trttnrerEuintvo lgsae:oyL.iec -idcoe)sncaltblu/-mneo wmfo"e stolkam r(n-rineia eacle"F 4rM mceLuolr-nll/iliv nirsn tD-ipxt ewcnu iLi4homts-taAinrnisiptiP’/ cdojrro./nsfen arn flyuwlfLwteneooen idhumal

mw uus9$et j ,nrr tatb kneet ea rgilLr s,sia66daa2 r. n .pae%omd hyr9e-lpu itu